Role of vascular endothelial growth factor in protein loss of Ménétrier's disease

International Journal of Molecular Medicine

Volumn 18, Issue 4, 2006, Pages 571-576

  Takeda, Teiko ^a   Mitsuyama, Keiichi ^a   Tsuruta, Osamu ^a   Kuboyama, Shinichi ^a   Kitazaki, Shigehiko ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

M n trier's disease; Protein losing gastropathy; Transforming growth factor ; Vascular endothelial growth factor

Indexed keywords

CD31 ANTIGEN; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MENETRIER DISEASE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD31; BLOOD VESSELS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; GASTRITIS, HYPERTROPHIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846003251     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.4.571     Document Type: Article

References (35)

1. Gastritis. In: Morson & Dawson's Gastrointestinal Pathology Morson BC, et al (eds). 3rd edition, Blackwell Scientific Publications, London, pp94-119, 1990.
2. Takagi H, Jhappan C, Sharp R and Merlino G: Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor α in the stomach. J Clin Invest 90: 1161-1167, 1992.
3. Dempsey PJ, Goldenring JR, Soroka CJ, et al: Possible role of transforming growth factor α in the pathogenesis of Menetrier's disease: Supportive evidence from humans and transgenic mice. Gastroenterology 103: 1950-1963, 1992.
4. Kondo M, Ikezaki M, Kato H and Masuda M: Anti-fibrinolytic therapy of giant hypertrophic gastritis (Menetrier's Disease). Scand J Gastroenterol 13: 851-856, 1978.
5. Miura S, Asakura H and Tsuchiya M: Lymphatic abnormalities in protein-losing gastropathy, especially in Menetrier's disease. Angiology 32: 345-354, 1981.
6. Kelly DG, Miller LJ, Malagelada JR, et al. Giant hypertrophic gastropathy (Menetrier's disease): pharmacologic effects on protein leakage and mucosal ultrastructure. Gastroenterology 83: 581-589, 1982.
7. Settle SH, Washington K, Lind C, et al: Chronic treatment of Ménétrier's disease with Erbitux: Clinical efficacy and insight into pathophysiology. Clin Gastroenterol Hepatol 3: 654-659, 2005.
8. Senger DR, Galli SJ, Dvorak AM, et al: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
9. Senger DR, Connolly DT, Water LVD, et al: Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res 50: 1774-1778, 1990.
10. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
11. Leung DW, Cachianes G, Kuang WJ, et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
12. Keck PJ, Hauser SD, Krivi G, et al: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989.
13. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
14. Goldman CK, Kim J, Wong WL, et al: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiform pathophysiology. Mol Biol Cell 4: 121-133, 1993.
15. Detmar M, Brown LF, Claffey KP, et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in proriasis. J Exp Med 180: 1141-1146, 1994.
16. Wolfsen HC, Carpenter HA and Talley NJ: Menetrier's disease: A form of hypertrophic gastopathy or gastritis? Gastroenterology 104: 1310-1319, 1993.
17. Coffey RJ, Gangrosa LM, Damstrup L and Dempsey PJ: Basic action of transforming growth factor-α and related peptides. Eur J Gastroenterol Hepatol 7: 923-927, 1995.
18. Weinstein WM: Hypertrophic gastropathies (giant mucosal folds). In: Gastrointestinal Disease. Pathophysiology, Diagnosis, Management. Sleisenger MH, et al (eds). 5th edition, WB Saunders, Philadelphia, pp561-563, 1993.
19. Florent C, Vidon N, Flourie B, et a:. Gastric clearance of alpha-1-antitrypsin under cimetidine perfusion new test to detect protein-losing gastropathy. Dig Dis Sci 31: 12-15, 1986.
20. Takeda H, Takahashi T, Ajitsu S, et al: Protein-losing gastroenteropathy detected by technetium-99m-labeled human serum albumin. Am J Gastroenterol 86: 450-453, 1991.
21. Jaskiewicz K, Price SK, Zak J and Louwrens HD: Lymphocytic gastritis in nonulcer dyspepsia. Dig Dis Sci 136: 1079-1083, 1991.
22. Miettinen A, Karttunen TJ and Alavaikko M: Lymphocytics gastritis and Helicobacter pylori infection in gastric lymphoma. Gut 37: 471-476, 1995.
23. Parums DV, Cordell JL, Micklem K, et al: JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43: 752-757, 1990.
24. Horak ER, Leek R, Klenk N, et al: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
25. Hudson N, Balsitis M, Everitt S and Hawkey CJ: Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 37: 191-194, 1995.
26. Fan XJ, Chua A, Shahi CN, et al: Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut 35: 1379-1384, 1994.
27. Bartnik W, Remine SG, Chiba M, et al: Isolation and characterization of colonic intraepithelial and lamina proprial lymphocytes. Gastroenterology 78: 976-985, 1980.
28. Fujisaki K, Mitsuyama K, Toyonaga A, et al: Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 93: 249-252, 1998. (Pubitemid 29063978)
29. Hanatani M, Tanaka Y, Kondo S, et al: Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotech Biochem 59: 1958-1959, 1995.
30. Kohn S, Nagy JA, Dvorak HF and Dyorak AM: Pathway of macromolecular tracer transport across venules and small veins. Structural basis for hyperpermeability of tumor blood vessels. Lab Invest 67: 596-597, 1992.
31. Roberts WG and Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379, 1995.
32. Berse B, Brown LF, Water LVD, et al: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211-220, 1992.
33. Brown LF, Olbricht SM, Berse B, et al: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154: 2801-2807, 1995.
34. Uflacker R: Angiographic pattern of giant hypertrophic gastritis (Menetrier's disease). Br J Radiol 53: 909-911, 1980.
35. Pepper MS, Ferrara N, Orci L and Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906, 1991.